Medline shareholders elect 12 directors, approve executive compensation and auditor at 2026 annual meeting

Medline Inc.

All 12 director nominees elected; highest withheld votes were for Robert R. Schmidt with 43,976,750 withheld.
Advisory vote on executive compensation approved: 1,189,280,399 for, 6,203,145 against.
Advisory vote on frequency set to one year (1,195,424,539 votes); board adopts annual advisory vote.
Ratification of Ernst & Young as independent auditor for FY2026 approved: 1,211,242,117 for, 156,205 against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Medline Inc. shareholders approved Advisory Vote on the Frequency of Votes on Executive Compensation at the 2026-06-11 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders approved, on an advisory basis, a frequency of one year for future advisory votes on the Company’s executive compensation as follows:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Medline Inc. shareholders approved Election of 12 director nominees named in the proxy statement at the 2026-06-11 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders elected each of the 12 nominees to serve as a director of the Company for a one-year term expiring at the Company’s 2027 Annual Meeting of Stockholders as follows:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Medline Inc. shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-06-11 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders approved, on an advisory basis, the Company’s executive compensation as follows:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Medline Inc. shareholders approved Ratification of the Selection of Ernst & Young LLP as Independent Auditor for Fiscal Year 2026 at the 2026-06-11 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Stockholders ratified the selection of Ernst & Young LLP as the Company’s independent auditor for fiscal year 2026 as follows:

View on SEC.gov

1504 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Medline Inc. filing history →

Source: SEC EDGAR

accession 0002046386-26-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.